Positron Corporation cash flow statement POSC

Annual Quarterly

In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, Positron Corporation used $1.0 million of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q1 FY2014 Mar 31, 2014	Q4 FY2013 Dec 31, 2013	Q3 FY2013 Sep 30, 2013	Q2 FY2013 Jun 30, 2013	Q1 FY2013 Mar 31, 2013	Q4 FY2012 Dec 31, 2012
Operating
Depreciation and amortization	—	0	0	—	—	—	—	—	—
Stock-based compensation	—	0	5	0 -100.0%	1 +108.1%	0 -100.0%	0 -100.0%	0 -91.7%	0
Operating cash flow	—	-1	-1	-1 +6.1%	-1 -83.9%	-1 +37.2%	-1 -95.7%	-1 -116.4%	-1 +12.9%
Investing
Capital expenditures	—	—	—	0 +100.0%	0 -100.0%	0	0 -97.9%	0 -95.7%	0 +0.0%
Investing cash flow	—	—	—	-0 -100.0%	0 +100.0%	0	-0 +64.6%	-0 +95.5%	-0 +0.0%
Financing
Short-term debt repaid	—	—	0	—	—	—	—	—	—
Financing cash flow	—	0	-0	0 -75.7%	2 +936.9%	0 -77.6%	1 +150.4%	1 +47.0%	-0 -174.5%
Change in cash
Net change in cash	—	-1	-1	—	—	—	—	—	—
Free cash flow	—	—	—	-1 +5.9%	-1 -83.2%	-1 +35.8%	-1 -73.4%	-1 -103.0%	-1 +12.8%
Ratios
Free cash flow margin	—	—	—	-152.85%	-198.95%	-185.47%	-167.36%	-199.73%	-136.77%
Capital expenditures to revenue	—	—	—	0.44%	0.00%	3.99%	0.23%	0.27%	0.53%
Stock-based compensation to revenue	—	0.00%	4,488.82%	0.00%	119.33%	0.00%	0.00%	23.72%	72.22%
Cash conversion	—	—	—	—	-0.28x	-0.46x	-0.66x	-0.62x	-0.24x

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: POSC (OTC)
Fiscal year ends: December 31
Incorporated in: TX
Headquarters: Westmount, IL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 844985

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.